ClinConnect ClinConnect Logo
Search / Trial NCT06482827

Treatment for Diabetic Neuropathy Using Repetitive Transcranial Magnetic Stimulation

Launched by MCMASTER UNIVERSITY · Jun 26, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment called repetitive transcranial magnetic stimulation (rTMS) to see if it can help relieve symptoms of diabetic neuropathy. Diabetic neuropathy is a condition that can cause pain, tingling, and numbness in the feet and hands due to nerve damage from diabetes. Over a period of four weeks, participants will receive rTMS and will be closely monitored using questionnaires, nerve tests, and blood tests to check for any improvements in their symptoms.

To be eligible for this study, participants must have a diagnosis of diabetic neuropathy. However, if someone has certain medical conditions that prevent them from safely receiving rTMS or if they have a psychological condition that makes it hard to understand the study, they won't be able to participate. This study is open to adults of all genders, and while it is not yet recruiting participants, it aims to help improve the lives of those suffering from this challenging condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • A diagnosis of diabetic neuropathy
  • Exclusion Criteria:
  • Contraindications to transcranial magnetic stimulation
  • Known psychological diagnosis affecting comprehension
  • Inability to participate in the study

About Mcmaster University

McMaster University, a leading research institution located in Hamilton, Ontario, Canada, is renowned for its innovative approach to education and its commitment to advancing healthcare through rigorous clinical research. The university's diverse research programs are supported by a multidisciplinary team of experts dedicated to improving patient outcomes and public health. With a strong emphasis on evidence-based medicine, McMaster University actively engages in clinical trials that explore new therapies, interventions, and health technologies, fostering collaboration among researchers, healthcare professionals, and industry partners to translate findings into real-world applications.

Locations

Hamilton, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Aimee Nelson, PhD

Principal Investigator

McMaster University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported